Tuesday 14 February 2017

Edge of the Seat

I was going to post another gleeful blog yesterday as the combined portfolios returned to profit again, making back most of Friday's losses. I resisted because it might curse today. I needn't have resisted, as most of those gains were wiped out today and we went back into overall loss.

It's yo-yo time as each day it sneaks into profit and then back to loss. Every time some shares do well, another one spoils the party. Certainly edge of the seat action!

Today it was AMYT:Amryt Pharma that caused a big drop. RED:RedT Energy also let the side down, but TLOU:Tlou Energy was brilliant. Not as brilliant as CAML:Central Asia Metals yesterday, which soared 8% and although it took a small dip today, is still up 6% this week. It's now making £1,860 potential profit, firmly consolidating its place as Star Share, with nearest contender IQE:IQE £750 behind but catching up.

KIBO:Kibo Mining continues to frustrate, with a huge 14% spread and the bid price refusing to lift off 4.75p despite the offer price increasing to 5.5p. OPTI:Optibiotix is still stuck around 73p for the 3rd week. I'm seriously considering buying one last batch, as my average SIPP purchase price is 77p, so I can drag it a bit further down if I buy another 1,000 at the offer price of 74p. So tempting...

The dividend arrived from GVC:GVC Holdings today. It's a very healthy £67 and takes the dividends in my share/ISA accounts over £1,000. In fact altogether my dividends add up to £1,438 which is 2.4% of the combined portfolio cost. Given most of my shares don't pay dividends, that's a pretty good return and a lot better than my cash ISA was delivering. When you add that to the £9,169 combined profits from sales, it's 18% of the cost of the portfolio over 18 months, making about 12% a year. If I can keep that up then job's a good 'un!

No comments:

Post a Comment